Rezolute   Report issue

For profit Phase 1 Phase 2
Founded: Indiana PA United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2013
NCT01828723
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Antria | Antria Inc. | Rezolute